PEDIATRICS Vol. 3 No. 1 January 1949, pp. 75-81
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PERRY, T. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by PERRY, T. L.

THE USE OF CARONAMIDE IN PEDIATRICS

THOMAS L. PERRY M.D.1

1 The Childrens Hospital, Los Angeles, and the Department of Pediatrics, University of Southern California School of Medicine.

Twenty-one infants and children received combined intramuscular penicillin and oral caronamide therapy for periods ranging up to 8 weeks. Marked increases in the maximal and minimal serum penicillin levels were regularly obtained when caronamide was given in a daily dosage of from 0.4 to 0.8 gm./kg. body weight. No relation was observed between the height of serum caronamide levels and serum penicillin levels. Caronamide was found to inhibit reversibly the tubular excretion of phenol red. No serious toxic effects of the drug were observed. Several successfully treated patients are described briefly, and a suggestion is made as to the type of pediatric case in which the use of caronamide is indicated.

Submitted on June 29, 1948